Aytu Biopharma AYTU
NASDAQ AYTU
$2.14 -0.06 (-2.73%)
As of: Sep 30, 2026 · 3:59 PM EDT

Aytu Biopharma (AYTU) Total Non-Current Liabilities (2015 - 2026)

Updated

Aytu Biopharma (AYTU) reported Total Non-Current Liabilities of $15.07 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 64.2% from $42.15 million a year earlier and down 9.1% from the prior quarter.

Analysis

Aytu Biopharma (AYTU) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends

Dating back to fiscal Q3 2015, Aytu Biopharma's Total Non-Current Liabilities record includes 46 quarters.

  • Total Non-Current Liabilities has a five-year compound annual growth rate of -32.8% (FY2021 to FY2026).
  • By fiscal year, Total Non-Current Liabilities came in at $42.15 million in FY2025 (+49.7%), $28.15 million in FY2024 (+0.2%), $28.09 million in FY2023 (-65.1%) and $80.52 million in FY2022 (-26.5%).
  • The fiscal Q4 2026 figure ranks as the lowest quarterly Total Non-Current Liabilities since fiscal Q3 2024.
  • Year over year, Total Non-Current Liabilities gained in four of the last eight quarters, with growth averaging 4.5%.
  • The high point for year-over-year Total Non-Current Liabilities in five years was fiscal Q1 2022 (growth of 190.9%); the low point was fiscal Q3 2024 (a decline of 85.4%).
  • Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $16.57 million (Q3 2026), $42.24 million (Q2 2026) and $35.82 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 105.99 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 106.45 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -967.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 5.92 Bn
10 Aytu Biopharma 23.91 Mn -91.77 Mn 10.41 Mn 15.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.07 Mn
Mar 31, 2026 16.57 Mn
Dec 31, 2025 42.24 Mn
Sep 30, 2025 35.82 Mn
Jun 30, 2025 42.15 Mn
Mar 31, 2025 18.60 Mn
Dec 31, 2024 21.41 Mn
Sep 30, 2024 24.75 Mn
Jun 30, 2024 28.15 Mn
Mar 31, 2024 14.40 Mn
Dec 31, 2023 34.21 Mn
Sep 30, 2023 88.41 Mn
Jun 30, 2023 28.09 Mn
Mar 31, 2023 98.38 Mn
Dec 31, 2022 85.84 Mn
Sep 30, 2022 92.32 Mn
Jun 30, 2022 80.52 Mn
Mar 31, 2022 102.11 Mn
Dec 31, 2021 109.99 Mn
Sep 30, 2021 108.06 Mn
API Access

Aytu Biopharma Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=AYTU&period=max&api_key=YOUR_API_KEY